Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,066,823
-
Total 13F shares
-
7,241,315
-
Share change
-
-797,730
-
Total reported value
-
$62,973,380
-
Put/Call ratio
-
50%
-
Price per share
-
$8.71
-
Number of holders
-
72
-
Value change
-
-$7,065,660
-
Number of buys
-
37
-
Number of sells
-
25
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q4 2021
As of 31 Dec 2021 ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) had 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,241,315 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Janney Montgomery Scott LLC, NORTHERN TRUST CORP, Retirement Planning Co of New England, Inc., GOLDMAN SACHS GROUP INC, Nuveen Asset Management, LLC, and Kovack Advisors, Inc..
This table shows 72 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.